Transforming interventional radiology to deliver precision care

As demand for minimally invasive surgery continues to grow, GE HealthCare is committed to helping clinicians use image guidance technologies to their full potential by removing barriers in order to provide quality care to patients, with the goal of helping providers achieve better clinical and operational outcomes.

A trusted assistant for image guided therapies

The award-winning1 Allia Platform represents the culmination of a multi-year collaboration with interventionalists and surgeons aimed at enhancing user experience, improving workflow efficiency, and increasing the adoption of advanced image guidance in daily practice - all important factors in today’s constrained healthcare environment.

Designed to be a trusted assistant for image guided therapies – the Allia Platform features a robotic gantry with a smaller footprint than previous versions and other features to enhance user experience and improve workflow integration and efficiency. With just one click, users can access all of their essential functions to make it their own personalized workplace that meets the operator’s specific needs and preferences in the interventional or hybrid operating room. Similarly, with the redesigned C-arm making the controls more accessible, it enables an optimized ergonomic setup for the user’s clinical needs, even in complex working positions at the head, neck or left side.

Advancing the practice of image guided therapy with artificial intelligence and digitization

To further advance interventional innovation in image guided therapy, GE HealthCare continues to expand its offerings of solutions that utilize digitization and artificial intelligence (AI) to help clinicians deliver precision care.

ASSIST imaging software helps users easily access and use augmented reality to help precisely plan, guide and assess sophisticated interventional procedures with greater precision and dose efficiency.

  • Embo ASSIST AI is the latest addition to the suite of ASSIST solution offerings designed to automatically segment vascular structures to facilitate embolization workflow planning, as well as help clinicians visualize and anticipate the destination of potential injections to support their embolization strategy thanks to AI-based simulation.
  • Liver ASSIST Virtual Parenchyma[2] is a 3D Visualization software solution designed to provide AI based virtual parenchymography simulating injections dynamically and thus, enabling clinicians to perform liver embolization procedures with confidence.
To better support healthcare systems in minimizing patient care disruption, new solutions like Tube Watch provide enhanced service of interventional image-guided systems.

Tube Watch is a solution designed to remotely monitor and predict X-ray generation component failure, including the tube, to help prevent failures before any disruption occurs – converting potential unplanned downtime into planned events.

Expanding the capabilities of image guided systems through an open ecosystem

The transformation of healthcare is evolving at a rapid rate. As part of the company’s commitment to advancing the practice image-guided therapy, GE HealthCare continues to explore new technologies that complement and expand the capabilities of its core Allia IGS platform to help enable access to the best new technologies as well as support clinicians in delivering precision care.

The new INTERACT Touch feature transforms the capabilities of the Allia IGS Platform by allowing clinicians to control up to three different third-party devices[1] through one single touch panel without breaking the sterile environment or workflow modification. The first third party application available with INTERACT Touch is AVVIGO+™ Multi-Modality Guidance System from Boston Scientific.[2] The AVVIGO+ system integrated with the Allia Imaging System with INTERACT Touch gives clinicians multimodality control in just one click to help optimize workflow for clinicians performing complex intravascular imaging and physiology procedures.

OmnifyXR Interventional Suite[3] from MediView further expands the 3D capabilities of GE HealthCare’s image guided systems through an interventional augmented reality solution. The OmnifyXR solution allows the user the ability to simultaneously display up to four customized holographic projections of live imaging to help improve ergonomics regardless of working position. The user can also display 3D volume images in augmented reality for improved anatomy visualization to help clinicians better assess complex anatomies and inform clinical decision making. The solution also features remote collaboration, enabling clinicians to partner from a distance, train, proctor and facilitate collaborative care from the viewpoint of the clinician.

GE HealthCare and Centerline Biomedical, Inc continue their collaboration to improve visualization and guidance during endovascular procedures with the aim of reducing reliance upon radiation and contrast agents during interventions. The IOPS® (Intra-Operative Positioning System), the flagship product from Centerline Biomedical, utilizes patented algorithms to generate a patient-specific vascular map combined with electromagnetic tracking and smart sensor-equipped endovascular devices to provide interventionalists with 3D color visualization and real-time navigation through a patient's vascular system, much like consumers use GPS apps in their day-to-day lives for a map showing where they are and to navigate where they want to go.

To help unlock better outcomes for patients, GE HealthCare is also collaborating with Proximie to make the Allia IGS system a connected space for real time collaboration and access to data insights. The integrated platform empowers hospitals, surgeons and medical device companies to share information and expertise with colleagues around the world to help improve patient care – from expanding personal knowledge and refining techniques, to unlocking new efficiencies in the operating room.

New image guided therapy technologies in interventional cardiology

As clinicians work to treat cardiovascular disease (CVD), cardiology procedures continue to evolve as demand for minimally invasive surgery grows.[1  To further add to the company’s image guided therapy technologies, new innovations in interventional cardiology were announced last month as part of the company’s comprehensive portfolio of cardiology solutions and will be featured as part of this year’s interventional showcase at RSNA:

  • Allia IGS Pulse, the next generation of image-guided systems designed was designed to improve workflow for the diagnosis and treatment of cardiovascular diseases in interventional cardiology - providing exceptional image quality and optimized dose management regardless of patient size - including large and bariatric patients with a BMI of greater than 30.
  • 3D Stent, one of GE HealthCare’s latest tools available on the Allia system designed to provide clinicians with intuitive three-dimensional (3D) images for stent visualization without the need for additional contrast, device or cost.

For more information on GE Healthcare’s interventional technologies, visit GE HealthCare at booth #7326 for more information.

Additional information can be found at GE HealthCare’s RSNA 2023 Event Center site here.

Emily Niles

2Liver ASSIST Virtual Parenchyma solution includes Hepatic VCAR and FlightPlan for Liver with Parenchyma Analysis option and requires AW workstation with Volume Viewer, Volume Viewer Innova, Vision 2, VesselIQ Xpress, Autobone Xpress. These applications are sold separately.
FlightPlan for Liver with Parenchyma Analysis option may not be available for sale in all countries. Please refer to your sales representative for more information.
3within compatible systems
4Not available for sale in all countries.
5This product offering is not available in all markets. Please contact your sales rep for more details.
6Ali, Jason M, and Yasir Abu-Omar. “Minimally Invasive Cardiac surgery-a Fad or the Future?.” Journal of Thoracic Disease vol. 13,3 (2021): 1882-1885. doi:10.21037/jtd-2020-mics-12